Drug Discovery World

JUNE 12, 2024

The webinar will feature Dr Sylvia F Boj, Chief Scientific Officer of HUB Organoids. Before joining HUB, Dr Boj studied the role of TCF7L2 in regulating metabolism in the laboratory of Prof Hans Clevers at the Hubrecht Institute.

Laboratories 130

Laboratories Disease Regulations Drug Development 130

Agency IQ

MAY 3, 2024

This recurring feature compiles information from across EU agencies and institutions to deliver an overview of chemicals-related regulatory actions likely to happen in the month ahead, including planned legislation, consultations, webinars, meetings, and more. Fill out the form to read the full article.

Regulations 59

Regulations 59

Drug Discovery World

MAY 22, 2024

The webinar will feature Dr Sylvia F Boj, Chief Scientific Officer of HUB Organoids. Before joining HUB, Dr Boj studied the role of TCF7L2 in regulating metabolism in the laboratory of Prof Hans Clevers at the Hubrecht Institute.

Laboratories 147

Laboratories Disease Regulations Drug Development 147

Drug Discovery World

JUNE 5, 2024

The webinar will feature Dr Sylvia F Boj, Chief Scientific Officer of HUB Organoids. Before joining HUB, Dr Boj studied the role of TCF7L2 in regulating metabolism in the laboratory of Prof Hans Clevers at the Hubrecht Institute.

Laboratories 130

Laboratories Disease Regulations Drug Development 130

Agency IQ

OCTOBER 27, 2023

What we expect European regulators to do in November 2023 In this new recurring feature, AgencyIQ, through public data and previous analysis, determines what European medicine and device regulators will likely do in the month ahead, including key deadlines, meetings, events, planned regulations, comment periods, and more.

Regulations 40

Regulations Pharmaceuticals Production Packaging 40

Drug Discovery World

MAY 29, 2024

The webinar will feature Dr Sylvia F Boj, Chief Scientific Officer of HUB Organoids. Before joining HUB, Dr Boj studied the role of TCF7L2 in regulating metabolism in the laboratory of Prof Hans Clevers at the Hubrecht Institute.

Drugs 130

Drugs Laboratories Disease Regulations 130

Agency IQ

MARCH 1, 2024

This ongoing feature compiles information from across EU agencies and institutions to deliver an overview of chemicals-related regulatory actions likely to happen in the month ahead, including planned legislation, consultations, webinars, meetings, and more. Fill out the form to read the full article.

Regulations 59

Regulations 59

Agency IQ

FEBRUARY 2, 2024

This ongoing feature compiles information from across EU agencies and institutions to deliver an overview of chemicals-related regulatory actions likely to happen in the month ahead, including planned legislation, consultations, webinars, meetings, and more. Fill out the form to read the full article.

Regulations 59

Regulations 59

Agency IQ

DECEMBER 1, 2023

What we expect European regulators to do in December 2023 In this new recurring feature, AgencyIQ, through public data and previous analysis, determines what European medicine and device regulators will likely do in the month ahead, including key deadlines, meetings, events, planned regulations, comment periods, and more.

Regulations 40

Regulations Clinical Trials Production Biosimilars 40

Agency IQ

JANUARY 4, 2024

This ongoing feature compiles information from across EU agencies and institutions to deliver an overview of chemicals-related regulatory actions likely to happen in the month ahead, including planned legislation, consultations, webinars, meetings, and more. Fill out the form to read the full article.

Regulations 59

Regulations 59

FDA Law Blog: Biosimilars

MARCH 12, 2023

The COVID-19 pandemic emergency forced federal regulators to take extraordinary measures to ensure that patients were permitted continued access to important medicines. Please see detailed information in the attached flyer , including a link to register for our free webinar. Hyman, Phelps & McNamara, P.C.’s We hope you join us!

Regulations 98

Regulations Government FDA Drugs 98

Agency IQ

DECEMBER 1, 2023

This ongoing feature compiles information from across EU agencies and institutions to deliver an overview of chemicals-related regulatory actions likely to happen in the month ahead, including planned legislation, consultations, webinars, meetings, and more. Fill out the form to read the full article.

Regulations 59

Regulations 59

Drug Discovery World

JUNE 8, 2023

These immune-humanized platforms enable researchers to test a wide range of human-specific therapeutic approaches developed to either up or down regulate immune function.

Immune Response 130

Immune Response Laboratories Regulations Research 130

Agency IQ

OCTOBER 27, 2023

This ongoing feature compiles public information from across the EU to deliver an overview of all the chemical policy-related actions in the month ahead, including planned legislation, consultations, webinars, meetings, and more. Fill out the form to read the full article.

Regulations 59

Regulations 59

Drug Channels

AUGUST 21, 2020

As regular readers know, I believe the 340B Drug Pricing Program needs to evolve into a more transparent, properly regulated program. To help the industry learn more about 340B rebates, Kalderos is sponsoring a live video webinar: Evolving 340B: Moving from Discounts to Rebates. to 1:00 p.m. Registration is free and open to all.

Compliance 52

Compliance Regulations Drugs 52

Fierce BioTech

MAY 22, 2024

This webinar will delve into the benefits of Expanded Access Programs in Europe. In addition, EAPs can help serve as introductions to the dizzying array of regulations and guidelines in European countries. png Listing Introduction This webinar will delve into the benefits of Expanded Access Programs in Europe.

Marketing 52

Marketing Regulations Pharmaceuticals Treatment 52

Agency IQ

MAY 31, 2024

What we expect the EPA to do in June 2024 The top line: In this returning feature, AgencyIQ looks at public data to determine what the EPA is planning to do in the month ahead, including deadlines, meetings, events, planned regulations, comment periods, and more. This is what OIRA is currently reviewing.

Regulations 40

Regulations Engineering International Research 40

Eye on FDA

JUNE 27, 2020

But in the United States, there are also an array of anti-discrimination laws; there are health privacy laws at both he federal and state levels; and there are regulations that guide what constitutes a safe workplace. You can register for the free Webinar here. It is not as uncomplicated as one might think. Share this:

Virus 52

Virus Vaccine Regulations Disease 52

Agency IQ

MAY 3, 2024

What we expect the EPA to do in May 2024 In this returning feature, AgencyIQ looks at public data to determine what the EPA is planning to do in the month ahead, including deadlines, meetings, events, planned regulations, comment periods, and more. TSCA new chemicals procedural regulations. TSCA risk management rules.

Regulations 40

Regulations Government Engineering International 40

Fierce BioTech

APRIL 11, 2024

Don't miss out—register now for this essential webinar! Key takeaways: Plan ahead for storage needs, mitigate risk with a qualified partner, and how to find a provider who can meet your specific requirements. Click here to login. Listing Image Alcami_ListingLogo_250x190.png

Compliance 52

Compliance Pharmaceuticals Regulations FDA 52

Fierce BioTech

MAY 31, 2024

Listing Image QuartzListingLogo_250x190_sware.png Listing Introduction As AI capabilities push into GxP regulated business functions, how can Quality and IT teams partner to ensure they are properly controlled? Click here to login.

Production 52

Production Regulations Science 52

Fierce BioTech

NOVEMBER 21, 2023

The Contract Transformation of the Biotech and BioPharma Industry swheeler Tue, 11/21/2023 - 18:43 Tue, 12/19/2023 - 12:00 Resource Type Webinar Angelina Bellanton Simon Jones Duration 60 minutes Either you want to implement a CLM, or you don’t know how to fix the processes of the one you have in place. Either is a tough place to be in.

Regulations 52

Regulations Pharmaceuticals International 52

Conversations in Drug Development Trends

FEBRUARY 22, 2023

Our rare disease team at Worldwide will be hosting a panel discussion webinar with patient advocates active in Rare Disease Day events to synthesize the most salient conversations taking place. See their conversation below and register for the webinar to hear more from these advocates!

Disease 52

Disease Clinical Trials Trials Treatment 52

Fierce BioTech

JANUARY 19, 2024

Listing Image QuartzListingLogo_250x190_liveworld.png Listing Introduction Dive into the captivating world of social video in our upcoming webinar and explore the dynamic shifts in demographics and culture that have propelled video content to the forefront of social media platforms such as TikTok, Reels, and YouTube Shorts.

Compliance 52

Compliance Pharmaceutical Companies Pharmaceuticals Regulations 52

Fierce BioTech

MAY 15, 2024

But many life sciences organizations still rely on complex legacy IT infrastructures and struggle to make sense of constantly growing amounts of sensitive, regulated data. The cloud provides a better solution.

Science 52

Science Clinical Development Regulations Research 52

Fierce BioTech

OCTOBER 26, 2023

pesurya Thu, 10/26/2023 - 14:05 Tue, 12/05/2023 - 11:00 Resource Type Webinar Julie Bullock, PharmD Krithika Shetty, PhD Blaire Osborn, Ph.D. Are Gaps in Your Clinical Pharmacology Program Jeopardizing Your Drug’s Approval?

Clinical Pharmacology 52

Clinical Pharmacology Drug Development Regulations FDA 52

Fierce BioTech

AUGUST 14, 2023

This webinar will focus on the latest advancements in bioprocessing for cell and gene therapies (CGTs), including the improved consistency and reduced production costs associated with closed manufacturing. Listing Image Cytiva 250x190.png

Therapies 52

Therapies Production Regulations Treatment 52

Fierce BioTech

JUNE 22, 2023

pesurya Thu, 06/22/2023 - 12:49 Wed, 08/02/2023 - 14:00 Resource Type Webinar Duration 60 Minutes Identifying orphan drug candidates and optimizing treatment adherence can be challenging in the best of circumstances. Developing a patient support program blueprint that can be adapted to fit different European national regulations.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Drugs Disease 52

FDA Law Blog: Biosimilars

JANUARY 22, 2024

The tools it uses to accomplish that mission include those designed to help regulated entities that want to follow best public health practices, like guidances, public notifications, and requests for information. Communication in this area included on-line videos, webinars, summits, conferences, and international outreach.

Compliance 59

Compliance Online Pharmacies Clinical Trials FDA 59

Perficient: Drug Development

SEPTEMBER 5, 2023

Despite many federal and state regulations aimed at improving the safety of utilities workers in the United States, there are several fatalities and many more injuries every year resulting from arc flash incidents on the job. Who will this affect, and what resources will be needed? How much will this cost? Can it be capitalized? ”

Regulations 52

Regulations Engineering 52

Drug Channels

DECEMBER 17, 2021

This week, I’m rerunning some popular posts while I prepare for today's live video webinar: Drug Channels Outlook 2022. This tale neatly summarizes why so many people hate our healthcare system—and why the average patient will have trouble benefiting from transparency regulations. See you soon! d/b/a Drug Channels Institute.

Hospitals 98

Hospitals Regulations Drugs 98

The Pharma Data

SEPTEMBER 15, 2020

Regulation in biotech can be both a barrier and a solution for innovating the drug discovery process as the pharma industry shifts from blockbuster products toward new individualized forms of medicine. Balance risk and innovation in regulation using new digital-therapy products. Add bookmark. Download Your Copy.

Regulations 52

Regulations Production Therapies Treatment 52

Fierce BioTech

OCTOBER 26, 2023

Are you struggling to keep track of privacy and compliance regulations across multiple countries and grant types? For example, are manual workflows and lengthy approval processes delaying your ability to deliver products or treatments to patients in need?

Compliance 52

Compliance Regulations Science Production 52

Agency IQ

FEBRUARY 15, 2024

MHRA selects eight technologies to help it test its new innovative devices pathway The British regulator and its partners just released the list of products and companies chosen to participate in the pilot of its Innovative Device Access Pathway (IDAP). device regulations and the pilot for innovative products. Life Sciences Vision.

Regulations 40

Regulations Production Science Vaccine 40

Agency IQ

MARCH 1, 2024

What we expect the EPA to do in March 2024 In this returning feature, AgencyIQ looks at public data to determine what the EPA is planning to do in the month ahead, including deadlines, meetings, events, planned regulations, comment periods, and more. PFAS regulations for drinking water.

Regulations 40

Regulations Compliance Government Production 40

Agency IQ

MAY 3, 2024

What We Expect the FDA to do in May and June 2024 In this ongoing feature, AgencyIQ looks at public data to determine what the FDA is likely to do in the months ahead, including key deadlines, meetings, events, planned regulations, comment periods and more.

FDA 40

FDA Science Regulations Clinical Trials 40

Conversations in Drug Development Trends

JUNE 21, 2024

Clinical researchers are currently working to streamline TIL production and enhance treatment outcomes by more efficiently regulating immune responses — such as combination therapy with checkpoint inhibitors. Check out this webinar on navigating the landscape of oncology clinical trials. Interested in hearing more insights from Matt?

Clinical Trials 64

Clinical Trials Clinical Research Immune Response Therapies 64